This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
What's in Store for Lincoln National (LNC) in Q1 Earnings?
by Zacks Equity Research
Lincoln National (LNC) Q1 earnings to gain from higher revenues, partly offset by rise in expenses.
CNA Financial (CNA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CNA Financial's (CNA) first-quarter results are likely to benefit from solid performances from its segments - Commercial and Specialty.
What's in the Offing for Aon (AON) This Earnings Season?
by Zacks Equity Research
Aon's (AON) first-quarter earnings are likely to benefit from solid segmental performances.
What's in the Cards for Marsh & McLennan (MMC) Q1 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results are likely to gain from a solid revenue contribution.
Total System (TSS) to Report 1Q Earnings: Will It Beat?
by Zacks Equity Research
Total System's (TSS) Q1 results should gain from increase in revenues, partly offset by rise in expenses.
Why Should You Add RenaissanceRe (RNR) to Your Portfolio?
by Zacks Equity Research
Riding high on robust premiums and reduced expenses, RenaissanceRe (RNR) holds immense potential to reap benefits for investors.
Marsh & McLennan's (MMC) Unit Buyout to Enhance Offerings
by Zacks Equity Research
Marsh & McLennan's (MMC) arm to purchase Centurion for enriching its product portfolio and enhancing the service suite.
RenaissanceRe to Consolidate Presence in Reinsurance Market
by Zacks Equity Research
RenaissanceRe (RNR) gets an approval to buy Tokio Millennium Re AG and Tokio Millennium Re (UK) Limited ("TMR") to make further inroads into the reinsurance market.
RenaissanceRe's (RNR) Q4 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) Q4 earnings gain on the back of solid underwriting, better revenues and gross-to-net strategy.
Why RenaissanceRe (RNR) Could Beat Earnings Estimates Again
by Zacks Equity Research
RenaissanceRe (RNR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
First American vs. RenaissanceRe Holdings: Which is Better?
by Zacks Equity Research
On comparative scales of judgment, we try and find out which stock ??? First American (FAF) or RenaissanceRe Holdings (RNR) ??? is a more profitable bet in view of the fundamentals.
Why Is RenaissanceRe (RNR) Up 6.5% Since Last Earnings Report?
by Zacks Equity Research
RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RenaissanceRe's (RNR) Q3 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
RenaissanceRe's (RNR) third-quarter earnings grow on higher revenues.
RenaissanceRe's (RNR) Q3 Earnings: What's in the Cards?
by Zacks Equity Research
RenaissanceRe's (RNR) Q3 is likely to fare better results on the back of Casualty and Specialty as well as Property segments, partially offset by high catastrophe loss.
RenaissanceRe (RNR) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
RenaissanceRe (RNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RNR vs. PGR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RNR vs. PGR: Which Stock Is the Better Value Option?
Is RenaissanceRe (RNR) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can Higher Premiums Contribute to Chubb's (CB) Q3 Earnings?
by Zacks Equity Research
Premium growth as well as better investment results are likely to drive Chubb's results (CB) in Q3. However, exposure to catastrophe loss might be a dampener.
Can Higher Premiums Drive Travelers' (TRV) Q3 Earnings?
by Zacks Equity Research
Strong growth across businesses, improved combined ratio along with higher premiums and better investment results might aid Travelers (TRV) in Q3. But cat loss exposure might be a spoilsport.
Will Higher Premiums Aid Progressive's (PGR) Q3 Earnings?
by Zacks Equity Research
Progressive's (PGR) third-quarter earnings are likely to be driven by increasing premiums and solid policies-in-force, partially offset by catastrophe losses.
Here's Why You Should Add Progressive (PGR) to Your Portfolio
by Zacks Equity Research
Progressive Corporation (PGR) promises exciting returns for investors on the back of five factors.
Everest Re Gains From Wide Product Portfolio, Cat Loss a Woe
by Zacks Equity Research
Everest Re (RE) continues to impress with wide product portfolio, top-line growth and robust capital position. However, exposure to cat loss remain a dampener.
Can Amerisafe Grow on the Back of Rising Net Premiums?
by Zacks Equity Research
Amerisafe (AMSF) is well poised to rise on solid net premiums growth.
CNA Financial Gains From Premium Growth, Costs on the Rise
by Zacks Equity Research
CNA Financial (CNA) continues to impress with premium growth, better performing Long Term Care business and robust capital position. However, rising costs remain a dampener.